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2Risk Assessment Components
• Risk assessment Tools
– Probabilistic Risk Assessment
– Integrated Medical Model
• Data
– Astronaut (LSAH)
– Analogs
• Data informs the decision process for 
determining flight-qualified crew
3What is Risk?
• Definition
¾ “The likelihood and severity of harm or adverse 
consequence.” [Overview of PRA, 5th NASA PRA Workshop]
¾ “The combination of 1) the probability (qualitative or 
quantitative) that a program or project will experience 
an undesired event such as a cost overrun, schedule 
slippage, safety mishap, or failure to achieve a 
needed technological breakthrough; and 2) the 
consequences, impact, or severity of the undesired 
event were it to occur.” [NPR 8000.4]
• For human space flight, the set of risks has been 
identified and catalogued in the Bioastronautics
Roadmap [http://bioastroroadmap.nasa.gov/]
4What is PRA?
“PRA is a systematic and comprehensive methodology to 
evaluate risks associated with every life-cycle aspect of a 
complex engineered technological entity (e.g., facility, 
spacecraft, or power plant) from concept definition, 
through design, construction and operation, and up to 
removal from service.”
Dr. Michael G. Stamatelatos, Director
Safety and Assurance Requirements Division
NASA HQ
As modified for space life sciences:
“PRA is a systematic and comprehensive methodology to 
evaluate risks associated with every aspect of human 
health in space flight.”
A way to improve decision-making by providing relative 
order of magnitude differences between risks
• What can go wrong?
• How likely is it?
• What are the consequences?
5ISS PRA
• First in NASA to include human health 
risks
• Risks evaluated based on expert 
opinion & statistical data, circa 1997
– Initiating events originated on ground-
based historical data
– Some mitigation events founded only on 
expert opinion
• Update in progress
– Astronaut data (e.g., Longitudinal Study of 
Astronaut Health, LSAH)
– Actual occurrence of events since 1997
– Match to current human health standards
6ISS PRA Medical Event 
Models 
• ISS Safety & Mission Assurance maintains PRA 
model of ISS, including crew medical emergencies
• Model compares relative risk of undesired events
– Loss of Vehicle (LOV)
– Loss of Crew (LOC)
– Crew Evacuation (EVAC)
– Loss of Critical System (LOSys)
• Three types of medical emergency event sequences 
developed
1. Treatment is available on board ISS
2. Treatment is not available on board ISS
3. Death immediately occurs (“Occupational hazards”)
• Medical issues are leading risk drivers in ISS 
model for LOC and EVAC end states
7Objectives of
Human System PRA Project 
• Evaluate human health risks of space flight 
using Probabilistic Risk Assessment (PRA) 
techniques
• Update the human health aspects of PRA for 
International Space Station (ISS)
• Use ISS PRA heritage to develop methods to 
integrate human health risks into PRA for 
Exploration-class missions
• Overall: to enable an informed decision-making 
process
8What is the Integrated 
Medical Model?
• Combation of astronaut and analog data to 
develop a more precise understanding of 
risk
• Determine risk in context: 
– Medical risk factors
– Tasks being performed
– Equipment availability
– Caregiver skill set
– Etc.
9Integrated Medical Model
Mission Modifiers
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Integrated Medical Model (IMM) Blueprint
MEDICAL SYSTEM ATTRIBUTES
• Component ID#
• Item Description
• Mass (kg)
• Stowed Volume (cm3)
• Vehicle Power (Watts)
• Battery Power (Watts)
• Total Cost (U$)
– Purchase Cost (U$)
– Flight Cert. Cost U$)
– Launch Cost (U$)
– Sustain. Cost (U$)
• Reliability (% mission time)
• References/Info Sources
CREW ATTRIBUTES
• Crew ID #
• Age (years)
• Gender (M/F)
• Country of Origin/Life 
Expectancy (years)
• Medical History
– Refer to EMR…
– Blood Pressure
– HDL/LDL
– ECG
– CBC
– Etc,
TREATMENT PROTOCOL IN-FLIGHT
• Task ID#
• Medical Task Description
• Task Time Required (min.)
• In-flight Space Factor (1.3)
• Space Task Time (1.3 x min.)
• Required Equipment (ID#)
• Required Training (hours)
• Actual Training (hours)
• Human Reliability Index
• References/Info Sources
MISSION PROFILE
• Duration (Days)
• Crew Compliment (# of 
Crew)
• Vehicle System 
Resources
• Vehicle System 
Reliability Rates
• Operational Constraints
• Acceleration (g) Profiles
• References/Info 
Sources
TREATMENT v OUTCOME ARRAYS
• Medical Disorder ID#
– Disorder Description
– Incidence Rate (events-crew-
day)
• Literature Review
• Linear Regression 
Algorithm
– Treatment Options
• Terrestrial Standard of 
Care; Gold Standard
• In-flight Treatment Option
• Untreated Case
– Outcome (% Whole Body 
Impairment)
• Event Tree Diagram
– Terrestrial 
Standard of Care
– In-flight Treatment 
Option
– Untreated
– References/Info Sources
MISSION TASKS 
• Mission Task ID#
• Task Description
• Duration (minutes)
• % Mission Duration (%)
• Required Crew Capabilities
– Physical
– Cognitive
• Impeding Medical Disorder(s)
– SNOMED #
• Reference/Info Sources
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Integrated Medical Risk Modeling 
Strategy
• Identification of medical conditions which may occur
• A best estimate of the probability and frequency of each identified 
condition with mission modifiers
• A generalized, universal metric for quantifying the relative loss 
contribution of outcomes, i.e., the impact or severity and identification 
of probability of modes outcomes of a medical condition
• Identification of the medical resources (skills, equipment and 
supplies) necessary to provide optimized modes of outcome for 
conditions, i.e., the mitigations 
• Use of a planning metric to rank effectiveness of nominated medical 
capabilities and their footprints for potentially achieving optimal 
outcomes (minimizing health and performance risks) compared to 
the Earth’s unconstrained medical resource (a measure of relative 
effectiveness and a quantified measure of loss of health and 
performance)
12
Longitudinal Study of Astronaut 
Health (LSAH)
• Cohort study – 3 comparison subjects for each astronaut 
matched by age, sex and body mass index at baseline
• Purpose:
– Examine mortality and morbidity rates (astronauts versus 
comparison subjects), 
– Determine the rate of illnesses and accidents that require 
medical care
– Facilitate investigations of occupational 
• Currently, there are 321 US astronauts and 982 
comparison participants in LSAH.
• Surveillance of comparison group is being expanded to 
parallel the astronaut examination schedule.
• Recruitment of payload specialists with spaceflight 
experience has been initiated to increase cohort 
exposed to spaceflight.
• Contains MRID data plus ground-based clinical data
13
LSAH Purpose
• The Longitudinal Study of Astronaut 
Health has been primarily used to 
determine the effects of spaceflight on 
astronauts.
• Question: Can LSAH be used to inform the 
flight qualification decision making 
process? (i.e. when is a waiver 
warranted?)
14
Capabilities
• Determine the fit of a qualified-to-fly population 
against the current screening criteria.
– Is the population near either extreme of the accepted 
range of values?
• Determine the number of medical incidents 
(ground and in flight)
• Determine the difference to an analog 
population
– Potentially interpret analog data based on known 
differences in astronaut risk factors.
15
Issues
• The number of astronauts is small.
– Cannot calculate an accurate incidence rate
• Astronauts are healthier than the general 
population
– Makes it difficult to find a good analog
16
Summary
17
Summary
• Human systems PRA
– Provides quantitative measures of probability, 
consequence, and uncertainty
– Communicates risk and informs decision-
making
• Human health risks rated highest in ISS 
PRA
– Based on 1997 assessment of clinical events 
in analog operational settings
• Much work remains to analyze remaining 
human health risks identified in 
Bioastronautics Roadmap
